Phosphorylation of APOBEC3G by protein kinase A regulates its interaction with HIV-1 Vif
- 5 October 2008
- journal article
- research article
- Published by Springer Nature in Nature Structural & Molecular Biology
- Vol. 15 (11) , 1184-1191
Abstract
The antiretroviral cytidine deaminase APOBEC3G inhibits HIV-1 replication, but the enzyme is targeted for degradation by HIV-1 Vif. Protein kinase A activity is known to be elevated in HIV-1–infected T cells. New data indicate that phosphorylation of APOBEC3G by protein kinase A renders the protein less susceptible to Vif-mediated degradation. Apolipoprotein B mRNA-editing enzyme catalytic polypeptide–like 3G (APOBEC3G, referred to here as A3G) is a potent antiretroviral host factor against human immunodeficiency virus type 1 (HIV-1). HIV-1 viral infectivity factor (Vif) counteracts A3G by promoting its degradation via the ubiquitin-proteasome pathway. Recent studies demonstrated that protein kinase A (PKA) phosphorylates activation-induced deaminase (AID), another member of the APOBEC3 family. A3G has two putative PKA phosphorylation residues. Here we show that PKA binds and specifically phosphorylates A3G at Thr32 in vitro and in vivo. This phosphorylation event reduces the binding of A3G to Vif and its subsequent ubiquitination and degradation, and thus promotes A3G antiviral activity. Computer-assisted structural modeling and mutagenesis studies suggest that the interaction between A3G Thr32 and Arg24 is crucial for interaction with Vif. These data imply that PKA-mediated phosphorylation of A3G can regulate the interaction between A3G and Vif.Keywords
This publication has 37 references indexed in Scilit:
- Cytidine deamination induced HIV-1 drug resistanceProceedings of the National Academy of Sciences, 2008
- Structure of the DNA deaminase domain of the HIV-1 restriction factor APOBEC3GNature, 2008
- Highly Conserved Configuration of Catalytic Amino Acid Residues among Calicivirus-Encoded ProteasesJournal of Virology, 2007
- A Single Amino Acid of the Human Immunodeficiency Virus Type 2 Capsid Affects Its Replication in the Presence of Cynomolgus Monkey and Human TRIM5αsJournal of Virology, 2007
- Identification of Amino Acid Residues in APOBEC3G Required for Regulation by Human Immunodeficiency Virus Type 1 Vif and Virion EncapsidationJournal of Virology, 2007
- The Enzymatic Activity of CEM15/Apobec-3G Is Essential for the Regulation of the Infectivity of HIV-1 Virion but Not a Sole Determinant of Its Antiviral ActivityJournal of Biological Chemistry, 2003
- DNA Deamination Mediates Innate Immunity to Retroviral InfectionCell, 2003
- Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcriptsNature, 2003
- Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif proteinNature, 2002
- Molecular Mechanism of Class Switch Recombination: Linkage with Somatic HypermutationAnnual Review of Immunology, 2002